[1]
L. Cakir, “Polypharmacy in Type 2 Diabetes Mellitus and Related Conditions: A Double-Edged Sword: A Narrative Review”, ADV CLIN PHARMACOL THER, vol. 2, no. 2, pp. 39–46, Sep. 2025, doi: 10.63623/sr9fb890.